Skip to Content
Merck

Prevent Protein Aggregation in Biopharma Formulations

Protein in bubble on yellow background

Protein stabilizers tackle one of the most critical challenges in biopharmaceutical production — preventing biomolecule aggregation at every stage of the biopharmaceutical process, formulation and manufacturing. Our products help you maintain the stability and therapeutic activity of your biopharmaceutical products to support consistent manufacturability, extended shelf life, and reliable therapeutic performance.

Key Benefits and Features


High-quality Protein Stabilizers

A portfolio of high-quality sugars, polyols, amino acids, and surfactants to protect your biomolecule from aggregation.


Low Endotoxin and Microbial Levels

Our Emprove® Expert portfolio is designed to meet regulatory requirements for high-risk applications, helping you reduce microbial contamination risks.


Industry-leading Documentation

Emprove® Program and comprehensive documentation to support your risk assessment efforts, including Elemental Impurity Information according to ICH Q3D.

Sugars and Polyols

Sugars and polyols protect the biomolecule against thermally induced instabilities, improving resistance elevated temperatures and temperature shifts during manufacturing, transport and storage.

View Products

Amino Acids

When used as excipients in biopharma formulations, amino acids act as protein stabilizers, buffering agents and antioxidants to help maintain product integrity.

View Products

Surfactants

To prevent surface or mechanically induced aggregation because of pumping or shaking, surfactants or cyclodextrin can be used to maintain protein integrity.

View Products

Viscosity Reduction Platform

In the case of highly concentrated protein formulations, the Viscosity Reduction Platform of proprietary excipient combinations is ideal to reduce viscosity while maintaining protein stability.

View Products

Emprove® Expert Portfolio: Meeting Regulatory Requirements of High-risk Applications

Our commitment to advancing pharmaceutical development is backed by the Emprove® Program, which provides comprehensive documentation to expedite your journey to market. For high-risk applications such as parenteral administration, our Emprove® Expert excipient portfolio is particularly well suited as it features specified low endotoxin and bioburden levels to support risk mitigation efforts.

Frequently Asked Questions

The structure of biomolecules, such as monoclonal antibodies and other proteins or peptides, is highly relevant for their therapeutic effect. Under certain conditions, biomolecules are highly susceptible to aggregation and unfolding which leads to reduced stability and a loss of functionality. Elevated temperatures, mechanical stress during manufacturing and transport, extreme pH conditions, and high protein concentrations can lead to partial unfolding of proteins, resulting in self-association and aggregates that compromise therapeutic activity and patient safety.

To enhance biomolecule stability, it is essential to ensure optimal formulation and environmental conditions such as optimal pH, avoiding high and low temperatures, and minimizing shear stress. Using stabilizing excipients like sugars, polyols, and amino acids can protect against thermal and mechanical stress, reducing the risk of protein aggregation during manufacturing, storage and administration.

Sugars and sugar alcohols (e.g., sucrose, trehalose, myo-inositol, mannitol) are commonly used as stabilizers in liquid formulations or during lyophilization. During lyophilization, they form a glass matrix that replaces water in hydrogen bonds, maintaining the protein's native structure. In solution, they shift the equilibrium towards the protein’s native folded state by strengthening the hydration shell or binding to the unfolded protein. Read our case study.

Proteins can form a film at hydrophobic interfaces, which is susceptible to rupture (e.g. through mechanical stress like shaking of the vial) and subsequent aggregation. Surfactants, such as polysorbates and poloxamers, stabilize proteins by preventing adsorption to these surfaces and binding to hydrophobic sites of the protein molecule. This keeps the protein in solution and lessens its susceptibility to mechanical stress. Learn more in our case study.

Amino acids can serve multiple roles in biopharmaceutical formulations, acting as stabilizers, buffering agents, and antioxidants. They help maintain the protein's native structure and can solubilize the biomolecule. Amino acids known for their stabilizing effects include glycine, arginine, histidine and amino acid derivative N-acetyl-DL-tryptophan.